Proxy war brews as activist investor Oracle targets Biolase board

Biolase steadies itself against a proxy war filed by activist majority shareholder Oracle Partners over alleged manipulation of the board of directors.

Biolase Technology Inc., Oracle Partners

Legal News, News Well, Dental, Laser/Light-based Devices, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1oilLX2